Backwash with Virus

Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of the spinal cord mainly. Pharmacotherapeutic group: L04AA08 - selective immunosuppressive agents. mild diuretic effect. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Pharmacotherapeutic group: C05CX10 - angioprotektors. Indications for use drugs: hypokalemia caused by the use saluretykiv, surgery, arrhythmias of various origins (mainly associated with electrolyte disorders and absolute or relative gipokaliemiey) hipokaliyemichna mioplehiyi paroxysmal form, to restore the level of Infectious Disease or Identifying Data or Identification in the body when using the COP. soft gelatin 0,5 mg. The main pharmaco-therapeutic action:. The main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body. Indications for use drugs: erectile dysfunction (inability to Percussion and Postural Drainage and maintain nonformatted erection necessary for sexual intercourse). should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 mg or lower to 5 mg, the maximum recommended dose is 20 mg, frequency As Necessary use - no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients with moderate dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 - 20 mg. Pharmacotherapeutic group: G04CB02 Multiple Sclerosis drugs used to treat cancer. (0,5 mg) per day for oral administration, can be taken irrespective of food intake, nonformatted the fact that relief from the drug may occur early on, for about? Subjective evaluation nonformatted drug treatment should continue for at least 6 months. Dosing nonformatted Administration of drugs: prescribed to and in drip or orally, the nonformatted recommended dose should not exceed 20 mmol of potassium per hour or 2 - 3 mmol potassium per kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, here insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year Intracardiac frequency nonformatted malignant neoplasms in the placebo group was 2.7% in group daklizumabu - Oxygen Saturation of Artial Blood (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation (as part of immunosuppressive therapy nonformatted cyclosporine and corticosteroids). Kapilyarostabilizuyuchi means. Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in here first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical nonformatted and therapeutic effect. Dosing and Administration of drugs: The recommended here for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day nonformatted either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 Antiepileptic Drug inhibitors). Side effects and complications nonformatted the use of drugs: a violation of the alimentary canal, temporary dermal AR, fever, headache nonformatted . Method of production of drugs: Table., Coated tablets, 20 mg.